View in EDS HTML Full Text PDF Full Text

SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia.

Saved in:
Bibliographic Details
Title: SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia.
Authors: Johansson P; Department of Hematology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. patricia.johansson@uk-essen.de.; Institute of Cell Biology (Cancer Research), University Hospital Essen, University of Duisburg-Essen, Essen, Germany. patricia.johansson@uk-essen.de., Klein-Hitpass L; Institute of Cell Biology (Cancer Research), University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Choidas A; Lead Discovery Center GmbH, Dortmund, Germany., Habenberger P; Lead Discovery Center GmbH, Dortmund, Germany., Mahboubi B; Center for Drug Discovery, Department of Pediatrics, Emory Center for AIDS Research, Emory University, Children's Healthcare of Atlanta, Atlanta, GA, USA., Kim B; Center for Drug Discovery, Department of Pediatrics, Emory Center for AIDS Research, Emory University, Children's Healthcare of Atlanta, Atlanta, GA, USA., Bergmann A; Institute for Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig Holstein, Kiel, Germany., Scholtysik R; Institute of Cell Biology (Cancer Research), University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Brauser M; Institute of Cell Biology (Cancer Research), University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Lollies A; Institute of Cell Biology (Cancer Research), University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Siebert R; Institute for Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig Holstein, Kiel, Germany.; Institute of Human Genetics, University of Ulm and University Hospital of Ulm, Ulm, Germany., Zenz T; Department of Molecular Therapy in Haematology and Oncology, National Center for Tumor Diseases and German Cancer Research Center, Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany., Dührsen U; Department of Hematology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Küppers R; Institute of Cell Biology (Cancer Research), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany., Dürig J; Department of Hematology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.
Source: Blood cancer journal [Blood Cancer J] 2018 Jan 19; Vol. 8 (1), pp. 11. Date of Electronic Publication: 2018 Jan 19.
Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 29352181
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Johansson+P%22">Johansson P</searchLink>; Department of Hematology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. patricia.johansson@uk-essen.de.; Institute of Cell Biology (Cancer Research), University Hospital Essen, University of Duisburg-Essen, Essen, Germany. patricia.johansson@uk-essen.de.<br /><searchLink fieldCode="AU" term="%22Klein-Hitpass+L%22">Klein-Hitpass L</searchLink>; Institute of Cell Biology (Cancer Research), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Choidas+A%22">Choidas A</searchLink>; Lead Discovery Center GmbH, Dortmund, Germany.<br /><searchLink fieldCode="AU" term="%22Habenberger+P%22">Habenberger P</searchLink>; Lead Discovery Center GmbH, Dortmund, Germany.<br /><searchLink fieldCode="AU" term="%22Mahboubi+B%22">Mahboubi B</searchLink>; Center for Drug Discovery, Department of Pediatrics, Emory Center for AIDS Research, Emory University, Children's Healthcare of Atlanta, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Kim+B%22">Kim B</searchLink>; Center for Drug Discovery, Department of Pediatrics, Emory Center for AIDS Research, Emory University, Children's Healthcare of Atlanta, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Bergmann+A%22">Bergmann A</searchLink>; Institute for Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig Holstein, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Scholtysik+R%22">Scholtysik R</searchLink>; Institute of Cell Biology (Cancer Research), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Brauser+M%22">Brauser M</searchLink>; Institute of Cell Biology (Cancer Research), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Lollies+A%22">Lollies A</searchLink>; Institute of Cell Biology (Cancer Research), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Siebert+R%22">Siebert R</searchLink>; Institute for Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig Holstein, Kiel, Germany.; Institute of Human Genetics, University of Ulm and University Hospital of Ulm, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Zenz+T%22">Zenz T</searchLink>; Department of Molecular Therapy in Haematology and Oncology, National Center for Tumor Diseases and German Cancer Research Center, Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Dührsen+U%22">Dührsen U</searchLink>; Department of Hematology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Küppers+R%22">Küppers R</searchLink>; Institute of Cell Biology (Cancer Research), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Dürig+J%22">Dürig J</searchLink>; Department of Hematology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568469%22">Blood cancer journal</searchLink> [Blood Cancer J] 2018 Jan 19; Vol. 8 (1), pp. 11. <i>Date of Electronic Publication: </i>2018 Jan 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101568469 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2044-5385 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220445385%22">20445385 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer J <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29352181
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41408-017-0036-5
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 11
    Titles:
      – TitleFull: SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Johansson P
      – PersonEntity:
          Name:
            NameFull: Klein-Hitpass L
      – PersonEntity:
          Name:
            NameFull: Choidas A
      – PersonEntity:
          Name:
            NameFull: Habenberger P
      – PersonEntity:
          Name:
            NameFull: Mahboubi B
      – PersonEntity:
          Name:
            NameFull: Kim B
      – PersonEntity:
          Name:
            NameFull: Bergmann A
      – PersonEntity:
          Name:
            NameFull: Scholtysik R
      – PersonEntity:
          Name:
            NameFull: Brauser M
      – PersonEntity:
          Name:
            NameFull: Lollies A
      – PersonEntity:
          Name:
            NameFull: Siebert R
      – PersonEntity:
          Name:
            NameFull: Zenz T
      – PersonEntity:
          Name:
            NameFull: Dührsen U
      – PersonEntity:
          Name:
            NameFull: Küppers R
      – PersonEntity:
          Name:
            NameFull: Dürig J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 01
              Text: 2018 Jan 19
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-electronic
              Value: 2044-5385
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Blood cancer journal
              Type: main
ResultId 1